Home Creators Posts Import Register Favorites Logout

Downloads

  • Louisa Nicola_Patreon.mp3

Some files exceed the archive size limit and weren't saved: 1 file. Please note these limits are in place to keep this site running long term, without costing a fortune. You can favorite the creator though, certain milestones increase the limit.

Content

Louisa Nicola is a neurophysiologist, performance specialist, and founder of Neuro Athletics, a company focused on brain optimization and neurophysiology for elite performers. A former professional triathlete, Nicola’s early career in endurance sport shaped her belief that peak performance is driven as much by the brain as by the body. Her transition from elite competition to neuroscience was fueled by a desire to understand the neurological foundations of reaction time, resilience, recovery, and long-term cognitive health.

Through Neuro Athletics, she works with professional athletes, sports organizations, executives, and high performers to implement measurable brain-based training protocols. Her work includes cognitive performance testing, visual processing and reaction training, nervous system regulation, and concussion recovery strategies. Nicola emphasizes objective brain metrics over subjective feedback, bringing scientific rigor to performance optimization.

She is also the host of The Neuro Experience podcast, where she interviews leading neuroscientists, physicians, and longevity experts. A significant focus of her public work centers on Alzheimer’s prevention and cognitive decline. Nicola advocates for early baseline testing, cardiovascular and metabolic health, strength and aerobic training to increase BDNF, sleep optimization, inflammation reduction, and lifelong cognitive engagement. She frequently highlights the disproportionate risk women face in Alzheimer’s disease and calls for greater awareness around hormonal and midlife cognitive vulnerability.

Nicola frames brain health as a lifelong discipline, connecting elite performance principles with long-term cognitive resilience and positioning brain optimization not as a reactive measure, but as a proactive strategy beginning in early adulthood.

Files

Comments

Hunter.F

To be honest, not my favorite. She speaks about how big Pharma is bad, and then defends them. She lost me when she starts defending vaccines. Her specialty is Alzteimers, not pharmaceuticals. She also didn't speak once about creatine and how much it helps with cognitive function, and preventing it. Also, Statins killed my father, and thats a fact I could share. Still, always a great day when a new SRS pod drops!

Cory

We used to clean parts in trich

Laykai

According to the NIH and PubMed statins DO show increased dementia risk, increasing the longer taken....and it's suggested you take them forever. What bothers me is that normal cholesterol was 250-310 in 1981 at age 50 and older. What did the pharmaceutical come up with at that time? Statins. If your doctor does not ask what you eat, and what you supplement and your lifestyle, find a new Dr.

SquidwardTentacles69

She seems well intentioned but naive and misinformed about some of these pharmaceutical drugs she advocated for on here

clarissa kopchak

I was I intrigued until she starting promoting vaccines. HPV is one of the worst with side effects and only “protects” against certain strains not 100% Cervical cancer accounts for approximately 1.3%of all new female cancer cases in Australia. In the US it’s .6% so Australia is actually double the rate. And what kid needs a flu shot ?

MVO

Unfortunately she is not as up to date on ALZHEIMERS progress. Does she even know about Dr Dale Bredesen? Also, here is a published study reversing dementia and there’s plenty of success stories Congratulations to Kerry Rutland, Dr. Neil Nathan, and Dr. Chi Kim on their landmark publication documenting the first example of reversal of cognitive decline in PCA (posterior cortical atrophy) (https://www.mdpi.com/2673-8937/6/2/20 ). PCA symptoms typically involve visual processing, so patients often lose the ability to read, have difficulty seeing cars when they drive, and have difficulty recognizing faces and objects in general. The underlying neuropathology in PCA is nearly always Alzheimer’s, as it was in this patient, and anywhere from 5-15% of Alzheimer’s patients begin with PCA. The patient reported in this paper regained her ability to read, was able to use her computer once again, improved her memory, improved her MRI volumetrics, and reduced her p-tau. Thank you to Kerry, Neil, and Chi for offering hope where there was none before.